SCHEMBL2590611

SCHEMBL2590611

CCCCCCCCCCCCCC(N)(N)OCC(O)CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.51
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
DGKA P23743 1/20 0.40
HTT P42858 2/20 0.39
SMPD1 P17405 4/20 0.38
PLA2G2C Q5R387 1/20 0.38
CYP2D6 P10635 2/20 0.37
FDPS P14324 1/20 0.37
SPHK1 Q9NYA1 1/20 0.37
GMNN O75496 1/20 0.37
POLB P06746 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867560 1.00 USP2 (0.51) USP2KDM4ELMNADUSP3MEN1
SCHEMBL10559210 0.81 USP2 (0.53) USP2KDM4ELMNADUSP3MEN1
SCHEMBL10420978 0.81 USP2 (0.53) USP2KDM4ELMNADUSP3MEN1
SCHEMBL2139322 0.81 USP2 (0.53) USP2KDM4ELMNADUSP3MEN1
SCHEMBL7096757 0.81 USP2 (0.53) USP2KDM4ELMNADUSP3MEN1
SCHEMBL5350631 0.79 USP2 (0.51) USP2KDM4ELMNADUSP3MEN1
SCHEMBL6150944 0.79 MEN1 (0.50) USP2KDM4ELMNADUSP3MEN1
SCHEMBL6150915 0.79 MEN1 (0.50) USP2KDM4ELMNADUSP3MEN1
SCHEMBL10420136 0.79 USP2 (0.50) USP2KDM4ELMNADUSP3MEN1
SCHEMBL28391309 0.78 USP2 (0.50) USP2KDM4ELMNADUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2512446-B1 COMPOSITION OF DEXIBUPROFEN TRANSDERMAL HYDROGEL SHASUN PHARMACEUTICALS LTD (IN) 2015-04-08 EP claimed
CN-118121644-A Application of sweet wormwood oil in inhibiting malassezia 中国中医科学院中药研究所 2024-06-04 CN disclosed
EP-3554498-A1 METHODS OF TREATING HYPERPIGMENTATION DISORDERS Chromaderm, Inc. (US) 2019-10-23 EP disclosed
WO-2018118874-A1 METHODS OF TREATING HYPERPIGMENTATION DISORDERS CHROMADERM, INC. (US) 2018-06-28 WO disclosed
WO-2015038951-A1 TOPICAL COMPOUNDS CONTAINING ADIPOSE-DERIVED HORMONES FOR THE REJUVENATION OF SKIN OHIO STATE INNOVATION FOUNDATION (US) 2015-03-19 WO disclosed
WO-2012056471-A2 NOVEL PROCESS FOR PREPARING DEXIBUPROFEN READY TO COMPRESS GRANULES SHASUN PHARMACEUTICALS LIMITED (IN) 2012-05-03 WO disclosed
WO-2011135591-A2 NOVEL TABLET COMPOSITION OF POLYALLYLAMINE POLYMERS SHASUN PHARMACEUTICALS LIMITED (IN) 2011-11-03 WO disclosed
EP-0885000-A2 TOPICAL COMPOSITIONS COMPRISING AN OIL-IN-WATER EMULSION AND A RETINOID Johnson & Johnson Consumer Companies, Inc. (US) 1998-12-23 EP disclosed
WO-1997031620-A2 TOPICAL COMPOSITIONS COMPRISING AN OIL-IN-WATER EMULSION AND A RETINOID JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) 1997-09-04 WO disclosed
WO-1996007396-A9 RETINOID COMPOSITIONS 1996-09-06 WO disclosed
WO-1996007396-A2 RETINOID COMPOSITIONS JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) 1996-03-14 WO disclosed